Lung Foundation Research Awards now open
Lung Foundation Australia has launched its 2014-2015 Research Awards Program.
Four research awards are available across several categories, with specific opportunities targeted towards medical or scientific graduates and medical or allied health professionals.
- The Lung Foundation Australia/Boehringer-Ingelheim Chronic Obstructive Pulmonary Disease Research Fellowship provides $80,000 for medical or scientific graduates working on population screening, diagnostic accuracy and management techniques for specific population groups through to system level issues in the health system.
- The Lung Foundation Australia/Ludwig Engel Grant-in-Aid for Physiological Research is specifically designed to assist research in respiratory physiology focussing on further understanding of organ function in the context of respiratory disease.
- The Lung Foundation Australia/Lizotte Family Research Award for Interstitial Pulmonary Fibrosis (IPF) Research is intended for medical or allied health professionals to fund an IPF related research or pilot project.
- The Lung Foundation Australia/Ivan Cash Grant-in-Aid for Idiopathic Pulmonary Fibrosis (IPF) Research project is aimed at a health care professional or scientist to publish a specific analysis of part or parts of the collected dataset of the Australian IPF Registry.
Applications for the research awards close on Monday 4 November, with presentations to the winners at the Annual Scientific Meeting of the Thoracic Society of Australia & New Zealand (TSANZ) in Adelaide from 4–9 April 2014.
Lung Foundation Australia CEO William Darbishire said the research awards supported the Foundation’s mission to reduce the burden of lung disease on patients, their families, their carers and the Australian community.
“These research awards are an excellent opportunity for universities, graduates and health care professionals interested in focusing their research on lung disease,” Mr Darbishire said.
“Lung disease is a significant and growing health issue for Australians with estimates that more than 7 million Australians aged 35 years or older may be at serious risk of lung disease,” he said.
For media enquiries, please contact Damon Cavalchini on 0411 609 681 or email firstname.lastname@example.org.